Abstract
The mechanisms mediating hepatic accumulation of inflammatory cells in cholestatic liver disease remain enigmatic. Our thesis is that Hedgehog (Hh) pathway activation promotes hepatic accumulation of immune cells that interact with cholangiocytes. We believe that myofibroblastic hepatic stellate cells (MF-HSC) release soluble Hh ligands that stimulate cholangiocytes to express chemokines that recruit mononuclear cell types with cognate receptors for these chemokines, thereby orchestrating a repair-related mechanism for liver inflammation. To address this thesis, we used three experimental systems that allow definition of Hh-dependent mechanisms that induce phenotypic changes in cholangiocytes. First, cholangiocytes were cultured alone or in the presence of Hh-producing MF-HSC in a transwell co-culture system and/or treated with MF-HSC-conditioned medium with or without Hh-neutralizing antibodies. Changes in cholangiocyte phenotype were then evaluated by microarray analysis, QRT-PCR, and/or ELISA for Cxcl16. Bile duct ligation was chosen to model biliary fibrosis in mice with an overly-active Hh pathway, control littermates, and healthy rats, and the gene profile was evaluated by QRT-PCR in whole liver tissue. Second, a transwell chemotaxis assay was used to examine NKT cell migration in response to cholangiocytes, particularly cholangiocyte-derived Cxcl16. Finally, we studied liver samples from PBC patients and controls by QRT PCR to compare differences in the Hh pathway and Cxcl16. Co-immunostaining of CK-7 and Cxcl16 was then performed to localize the phenotypic source of the Cxcl16. We found that MF-HSC release soluble Hh ligands that stimulate cholangiocytes to produce Cxcl16 and recruit NKT cells. Hh pathway activation during cholestatic liver injury also induces cholangiocyte expression of Cxcl16.
Conclusion
During biliary injury, Hh pathway activation induces cholangiocyte production of chemokines that recruit NKT cells to portal tracts.
Keywords: Cholangiocytes, Myofibroblasts, Natural Killer T cells, Bile duct ligation, Primary biliary cirrhosis
Hepatic accumulation of various types of inflammatory cells is a hallmark of many chronic cholestatic liver diseases.(1–3) Such cells often cluster in and around “neo-cholangioles” (ductular-like structures) and admix with fibroblastic cells in portal triads, but sometimes they extend deeper into hepatic lobules, particularly when liver injury is accompanied by fibrosis. Foci of dead and injured liver epithelial cells are typically associated with these inflammatory infiltrates, suggesting that the inflammatory cells themselves, and/or mediators that they release, are hepatotoxic.(2, 4) The resultant elimination of chronically infected and/or irrevocably-damaged hepatocytes and cholangiocytes may also be necessary for eventual recovery. In any case, evidence that the numbers of hepatic inflammatory cells and myofibroblasts dwindle as liver injury and fibrosis resolve supports the concept that hepatic accumulation of immune cells and fibrosing biliary injury are linked.(2, 4)
Biliary fibrosis is accompanied by activation of the Hedgehog (Hh) pathway in rodents and humans.(5–8) Hh ligands are pleiotropic morphogens that regulate tissue remodeling responses during embryogenesis and adult tissue repair.(6, 7, 9, 10) Two of the major cell types that are involved in repairing chronic biliary injury, immature ductular cells (cholangiocytes) and myofibroblastic hepatic stellate cells (MF-HSC), produce and respond to Hh ligands.(5, 7, 8, 11) Hh pathway activation promotes proliferation and enhances viability of both cell types, permitting accumulation of myofibroblastic cells and immature ductular cells in fibro-ductular bridges. When unrestrained, this causes progressive fibrosis and hepatic architectural distortion.(6, 7)
Certain types of T lymphocytes have been shown to be Hh-responsive in adults.(12, 13) Whether or not liver cell-derived Hh ligands have any role in regulating immune responses to liver injury has not, to our knowledge, been examined. This merits investigation, however, because immune cells contribute to liver remodeling and typically localize near collections of immature ductular cells and myofibroblasts in injured livers.(2, 14–16) Therefore, the current study focused on the thesis that the activation of the Hh pathway promotes the specific accumulation of immune cells that interact with cholangiocytes, and results in an orchestrated response that includes a repair-related mechanism for liver inflammation. Our results support the concept that paracrine Hh signaling between myofibroblasts and cholangiocytes promotes immune cell migration towards biliary epithelilal cells. These findings identify a mechanism that mediates this process, namely Hh-dependent induction of chemokine production by ductular-type cells. Moreover, functional analysis of one of these Hh-regulated chemokines, Cxcl16, provides compelling evidence for the pathobiological significance of such repair-related inflammation in chronic biliary disease in rodents and humans.
METHODS
Human subjects
Anonymized liver samples were examined from 14 patients with PBC and 7 control healthy livers. Tissues were obtained from UC Davis (Davis, CA), UT Southwestern (Dallas, TX) and Duke University School of Medicine Tissue Bank Shared Resource (Durham, NC), and studied in accordance with NIH guidelines for human subjects research.
Animals
Ptc-deficient mice (Ptc+/−) and their wild type (WT) littermates were obtained from P.A. Beachy (Johns Hopkins University, Baltimore, MD).(17) Fisher rats were obtained from Charles River (Wilmington, MA).
Cell lines
Murine cholangiocyte 603B line was provided by Yoshiyuki Ueno (Tohoku University, Sendai, Japan) and G. Gores (Mayo Clinic, Rochester, MN). (18, 19) Clonally-derived rat Myofibroblastic Hepatic Stellate Cell (MF-HSC) line 8B was obtained from M. Rojkind (George Washington University, Washington D.C.) (20) Normal rat cholangiocyte line (NRC) was a gift of N. LaRusso (Mayo Clinic, Rochester, MN).(21) Murine invariant NKT hybridoma cell line (DN32) was provided by Dr. Albert Bendelac (University of Chicago, Chicago, IL). (22)
Animal experiments
Mice and rats were subjected to bile duct ligation (BDL) or sham surgery (n=6 per group) and sacrificed after 1 week to obtain liver tissues (from mice) (5, 7) or cholangiocytes (from rats). Cholangiocytes were purified using a monoclonal antibody (from R. Faris, Brown University, Providence, RI) against a membrane antigen expressed by all intrahepatic cholangiocytes. (23) Purity of cholangiocytes was confirmed by cytochemistry for γ glutamil transpeptidase (γ GT), a cholangiocyte-specific marker.(5, 23) As assessed by trypan blue exclusion, cell viability was greater than 97% (5, 23). All animal experiments were approved by the Institutional Animal Care and Use Committees of Duke University and Scott and White Hospital as set forth in the “Guide for the Care and Use of Laboratory Animals” published by the National Institutes of Health.
Cell Culture Experiments
Assessment of MF-HSC-derived factors on cholangiocyte phenotype
Immature (7) cholangiocytes (603B cells) were cultured in 6 well plates for 6 days alone (monoculture) or in a trans-well co-culture system with MF-HSC (MF-HSC-8B) as described.(5, 7) In each experiment, mRNA and conditioned medium were pooled from all 6 wells, and used for subsequent microarray, QRT-PCR analysis, or ELISA. MF-HSC 8B cells were also mono-cultured for 6 days to obtain MF-HSC-conditioned medium for other studies (see below). All experiments were repeated three times.
Pharmacological inhibition of Hh signaling in vitro
Hh neutralizing antibody (5E1, Developmental Studies Hybridoma Bank, Iowa City, IA) or control IgG (R&D)(10μg/ml) was added to MF-HSC-conditioned medium, and used to treat cholangiocyte monocultures that had been serum-starved for 18h.(5) Cholangiocytes that were treated with unconditioned medium served as controls. 24h later, supernatants and cell pellets were harvested. Cxcl16 protein in supernatants was quantified by ELISA and mRNA extracted from cell pellets was analyzed by QRT-PCR for chemokine-related genes. (5, 7) These studies were repeated using freshly isolated, primary rat cholangiocytes, (23) and supernatants were harvested after 6 h for Cxcl16 quantification. All experiments were repeated three times.
Natural Killer T (NKT) cell migration assay
Mono-/co-cultures were repeated using 24 well plates.(5, 7) After 6 days, inserts containing MF-HSC were removed, conditioned medium was collected, and kept at −80°C until ELISA for Cxcl16 was performed. Mono-/co-cultured cholangiocytes were then treated with NKT cell culture medium + anti-Cxcl16 antibody (R&D Systems) or irrelevant IgG (5μg/mL). After 1h, a modified chemotaxis assay(24, 25) was performed. Briefly, new inserts (5μm pore size) were placed in the wells, and NKT cells (1.5×105/0.2 ml) were added to the upper chambers. Cultures were incubated at 37° C in 5% CO2 for 2 h, supernatants were collected from the bottom chamber, and NKT cells that had migrated through filters were quantified using a hemocytometer. Experiments were repeated three times.
Microarray analysis
Total RNA from mono- or co-cultured cholangiocytes (603B cells) was evaluated by microarray (N=3 samples per group).(5) After RNA quality was assessed using Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), RNA was hybridized to Mouse 430-2 Affymetrix GeneChips ® (Duke University Microarray Facility, Durham, NC).(5) The probe expression values of the GeneChips ® were subsequently calculated applying the Robust Multichip Average (RMA) algorithm by means of RMAExpress (5, 26–28) based on the Affymetrix CEL and CDF files as standard inputs. The RMA-based gene expression in the co-culture group was expressed as a ratio of the expression in the mono-culture control group. A 1.5-fold increase or decrease in relative gene expression (i.e., probes having an expression ratio in co-cultures/mono-cultures above 1.500 and below 0.666) was considered to be significant.(29, 30) These were further evaluated by gene ontology (GO) analysis.(31) Each gene probe was assigned to its GO families, and EASE scores were calculated.(32) Chemokine genes that were differentially-expressed in the micro-array analysis were then validated by QRT–PCR.
Two-step Real-Time PCR
Total RNA from cholangiocyte cell lines (603B and NRC), primary cholangiocytes or liver tissues was reverse transcribed to cDNA templates after RNase-free DNase I treatment (Qiagen, Valencia, CA). Semi-quantitative QRT–PCR was then performed.(5) Species-specific primers are listed in Table 1. Target gene expression was normalized to housekeeping gene expression according to the ΔΔCt method. In each experiment, data are expressed relative to the corresponding control group.(5) Amplicon products were also separated by electrophoresis on a 2.0% agarose gel buffered with 0.5× Tris-borate-EDTA (TBE) and representative products were then visualized using an AlphaImager 3400 Gel Analysis System.(7)
Table 1. Sequences of primers used for QRT-PCR.
Ccl2/MCP-1 (chemokine C-C motif ligand 2/monocyte chemotactic protein-1); Ccl5 (chemokine C-C motif ligand 5); Ccl20/MIP3α (chemokine C-C motif ligand 20/macrophage inflammatory protein-3α), Cxcl1 (chemokine C-X-C motif ligand 1); Cxcl2 (chemokine C-X-C motif ligand 2); Cxcl5 (chemokine C-X-C motif ligand 5); Cxcl10 (chemokine C-X-C motif ligand 10); Cxcl11 (chemokine C-X-C motif ligand 11); Cxcl16 (chemokine C-X-C motif ligand 16).
| Target Gene | Forward Sequence | Reverse Sequence |
|---|---|---|
| Ccl2/MCP1* | TGATCCCAATGAGTAGGCT | TCAGATTTACGGGTCAACTT |
| Ccl5* | CCCTCACCATCATCCTCACT | CCCTCACCATCATCCTCACT |
| Ccl20/MIP3α* | CCCAGCACTGAGTACATCAA | GTATGTACGAGAGGCAACAGTC |
| Cxcl1* | CCCAAACCGAAGTCATAGCC | TCAGAAGCCAGCGTTCACC |
| Cxcl2* | GCCCAGACAGAAGTCATAGCC | TTCTCTTTGGTTCTTCCGTTGA |
| Cxcl5* | TCATGAGAAGGCAATGCT | ACATTATGCCATACTACGAAGA |
| Cxcl10* | TGAATCCGGAATCTAAGACCAT | AAGACCAAGGGCAATTAGGACT |
| Cxcl11* | CCTGGCTGCGATCATCT | GCATTATGAGGCGAGCTT |
| Cxcl16* | TTCTTGTTGGCGCTGCTGAC | TGCGCTCAAAACAGTCCACTAG |
| S9* | GACTCCGGAACAAAGGTGAGGT | CTTCATCTTGCCCTCGTCCA |
| Ccl2/MCP1** | CAGTTAATGCCCCACTCACC | TTCCTTATTGGGGTCAGCAC |
| Ccl20/MIPα** | GCGAGAATTTTTGTGGGTTT | CGGATCTTTTCGACTTCAGG |
| Cxcl1** | AGACAGTGGCAGGGATTCAC | TGGCTATGACTTCGGTTTGG |
| Cxcl2** | GGCTTCAGGGTTGAGACAAA | AGGGTACAGGGGTTGTTGTG |
| Cxcl5** | AGTCGATTCCGCTTTGTTTT | AACCCCAAAATGATCGCTAA |
| Cxcl11** | TCAAAATGGCAGCAATCAAG | CCAGGCACCTTTGTCCTTTA |
| Cxcl16** | CCAGCAGTCCACTTTTCCAT | GCTCCTGGTTCTTTTTGCTG |
| S9** | GACTCCGGAACAAAGGTGAGGT | CTTCATCTTGCCCTCGTCCA |
| IFNγ*** | TGACCAGAGCATCCAAAAGA | CTCTTCGACCTCGAAACAGC |
| Cxcl16*** | ACTCGTCCCAATGAAACCAC | ATGAAGATGATGGCCAGGAG |
| β actin *** | TGGCATCCACGAAACTACCT | ACGGAGTACTTGCGCTCAG |
mouse,
rat
human
Cxcl16 ELISA
Cxcl16 protein was detected by DuoSet ELISA assay (R&D Systems) as per the manufacturer. Results were expressed as absolute concentration of Cxcl16 (pg/ml).
Immunohistochemistry
Frozen human liver sections were fixed, permeabilized, saturated, and processed for double immunofluorescent staining with primary antibody against Cxcl16 (R&D Systems) and CK-7 (Dako, Carpinteria, CA). Alexa Fluor 568 and Alexa Fluor 488 (Molecular Probes, Carlsbad, CA) were used as secondary antibodies. Counterstaining with 4′, 6-diamidino-2-phenylindole (DAPI) was employed to demonstrate nuclei.
Statistical Analysis
Results are expressed as mean ± Standard Error Mean (SEM). Comparisons between groups were performed using the Student’s t-test and significance was accepted at the 5% level, unless stated otherwise.
RESULTS
Paracrine Hedgehog signaling between ductular and myofibroblastic cells induced chemokine gene expression in ductular cells
Ductular-type cells and myofibroblastic cells typically localize together and accumulate in concert during chronic liver injury.(2) Our previous studies of a transwell co-culture system of cholangiocytes and MF-HSC demonstrated that each of these cell types released soluble Hh ligands that promoted the proliferation and viability of the other type of cell.(7, 11) To determine if MF-HSC generated soluble factors that also influenced the immunomodulatory properties of cholangiocytes, microarray analysis was done to compare genes expressed by co-cultured versus mono-cultured cholangiocytes. Interestingly, some of the most highly-induced genes in cholangiocytes regulated cytokine activity, inflammatory responses, chemotaxis, chemokines and antigen presentation/processing (Fig. 1A and Table 2). Since the major objective of this study was to determine if (and how) Hh pathway activation in liver cells might regulate hepatic accumulation of inflammatory cells, subsequent attention focused on differentially-expressed chemokines.
Fig. 1. Paracrine signaling between myofibroblastic and ductular cells induced chemokine gene expression in ductular cells.
(A) Chemokine related probe analysis Microarray analysis was performed in mono-/-co-culture samples derived from 3 independent experiments. Each probe having an expression ratio (average expression in co-cultures/average expression in monocultures) above 1.500 and below 0.666, was considered for the gene ontology (GO) analysis and assigned to its GO families. Probes belonging to Chemokine Activity, Chemokine receptor binding and Chemotaxis GeneOntology families are displayed as ratio of the expression in co-cultured vs mono-cultured cholangiocytes. (B) 2% Agarose gel of representative amplicon products QRT-PCR was performed in the murine cholangiocyte 603B line, rat NRC line and primary rat cholangiocytes using species-specific primers. Amplicon products were separated by electrophoresis on a 2% agarose gel buffered with 0.5× Tris-borate-EDTA (TBE) and then visualized using an AlphaImager 3400 Gel Analysis System. Ccl2/MCP-1 (chemokine C-C motif ligand 2/monocyte chemotactic protein-1); Ccl5 (chemokine C-C motif ligand 5); Ccl20/MIP3α (chemokine C-C motif ligand 20/macrophage inflammatory protein-3α), Cxcl1 (chemokine C-X-C motif ligand 1); Cxcl2 (chemokine C-X-C motif ligand 2); Cxcl5 (chemokine C-X-C motif ligand 5); Cxcl10 (chemokine C-X-C motif ligand 10); Cxcl11 (chemokine C-X-C motif ligand 11); Cxcl16 (chemokine C-X-C motif ligand 16).
Table 2. Significative change in chemokine related GeneOntology (GO) gene sets.
Gene probes having an expression ratio (co-cultures/mono-cultures) above 1.500 (upper threshold) and below 0.666 (lower threshold) respectively, were considered for the gene ontology (GO) analysis. Each gene probe was then assigned to its multiple GO families and significance (EASE score) was evaluated.
| GO FamilyA | Gene CountB | EASE ScoreC |
|---|---|---|
| Cytokine activity | 13 | 0.033000 |
| Inflammatory response | 10 | 0.042000 |
| Taxis | 10 | 0.003000 |
| Chemotaxis | 10 | 0.003000 |
| Chemokine receptor binding | 9 | 0.000007 |
| Chemokine activity | 9 | 0.000007 |
| Antigen processing, endogenous antigen via MHC class I | 5 | 0.039000 |
| Antigen presentation, endogenous antigen | 5 | 0.042000 |
Chemokine related GO families.
Absolute number of altered genes.
EASE Score.
Both microarray (Fig. 1A) and QRT-PCR (Fig. 2, black bars) analysis demonstrated that compared to mono-cultured cholangiocytes, co-cultured cholangiocytes expressed 2-fold to almost 40-fold higher levels of mRNAs encoding chemokines for neutrophils (Ccl20/MIP3α, Cxcl1, Cxcl2, Cxcl5)(33), monocytes/macrophages (Ccl2/MCP-1, Ccl20/MIP3α)(33, 34), and lymphocytes (Ccl20/MIP3α,(35–38) Cxcl11 (33, 39)), including natural killer (NK)T cells (Cxcl16 (40–42)). To assure that chemokine production was not a unique characteristic of the 603B cholangiocyte line, basal expression of chemokine mRNAs was also assessed in a second cholangiocyte line (NRC) (Fig 1B) and in primary rat cholangiocytes (Fig. 1B). Effects of biliary injury on cholangiocyte chemokine production was then examined by comparing levels of chemokine mRNAs in freshly isolated, primary cholangiocytes from rats that had undergone either sham surgery or BDL one week earlier. BDL significantly influenced cholangiocyte expression of all of the chemokine mRNAs that had been induced in the co-culture experiments (Fig 2, white bars).
Fig. 2. Microarray data validation and comparison with freshly isolated cholangiocytes by QRT-PCR analysis.
Chemokine gene mRNA levels were normalized to housekeeping gene expression in 603B mouse cholangiocytes or primary rat cholangiocytes. Data are displayed as fold-change in co-cultured 603B cholangiocytes relative to that in 603B mono-cultures (black bars), or in primary cholangiocytes isolated from 1 week BDL rat relative to sham controls (white bars). Data are representative of 3 experiments and shown as mean±SEM (*P<0.05, ** P<0.005).
To determine if Hh ligands released from MF-HSC mediated induction of chemokine genes in neighboring cholangiocytes, the studies in cultured 603B cells were repeated with MF-HSC-conditioned medium containing either control IgG or Hh-neutralizing antibody. Chemokine gene expression was consistently inhibited by adding Hh neutralizing antibody to MF-HSC-conditioned medium (Fig. 3A), proving that soluble Hh ligands mediated much of the stimulatory effects that MF-HSC exerted on cholangiocyte chemokine expression.
Fig. 3. Cholangiocyte chemokine gene induction is Hedgehog-dependent (A) QRT-PCR analysis of cholangiocytes cultured in myofibroblast-conditioned medium with or without Hh-neutralizing antibody.
MF-HSC 8B were cultured for 6 days and conditioned medium was collected. This MF-HSC-conditioned medium was then added to monocultures of cholangiocyte cell line 603B that had been cultured without serum for 18 hours. Cholangiocytes were incubated with MF-HSC conditioned medium in presence of Hh-neutralizing antibody (5E1) (grey bars) or control IgG (black bars) (10 μg/mL) for an additional 24 hours. 603B cells cultured in unconditioned medium (white bars) provided an additional control group. QRT-PCR was then performed to analyze the expression of chemokine-related genes that had been altered when the cholagiocytes were co-cultured with MF-HSC line 8B. Data are representative of 3 independent experiments and expressed as mean±SEM. (*P<0.05, ** P<0.005) (B) QRT-PCR analysis of whole liver tissue from bile duct ligated (BDL) mice. Ptc-deficient (Ptc +/−) mice (black bars) (n=6) and their WT littermates (white bars) (n=6) underwent BDL and were analyzed for the same chemokines that were Hh-dependent in vitro. Data are shown as mean±SEM (*P<0.05, ** P<0.005).
Enhanced induction of chemokine mRNAs after bile duction ligation in mice with excessive Hh pathway activity
To determine the role of Hh signaling on chemokine production during liver injury, we next compared expression of the same chemokine genes in Ptc+/− miceand their WT littermates one week after BDL. Mice with haplo-insufficiency of Ptc have an impaired ability to turn off Hh pathway signaling because Ptc normally restrains the activity of Smoothened, the signaling competent Hh co-receptor.(43) Hence, Ptc+/− mice are prone to develop diseases that result from excessive Hh pathway activity,(17, 44, 45) and we reported previously that Ptc+/− mice developed worse liver fibrosis than WT mice after BDL,(5, 7) a potent stimulus for activation of Hh signaling in the liver.(6, 7) In the current study, Ptc+/− mice exhibited generally greater expression of the chemokines that were Hh-responsive in the cholangiocyte cell line, demonstrating significantly greater expression of 6 of the 7 putative Hh-responsive chemokines than WT-BDL mice (Fig. 3B).
Hh-dependent paracrine mechanism stimulated ductular cells to synthesize and secrete Cxcl16 that chemoattracts NKT cells
Next we performed a more in depth functional analysis of Cxcl16, one of the chemokines that had proven to be Hh-inducible in both cultured cholangiocytes and BDL liver (Fig. 3). Cxcl16 was selected for scrutiny because it is a chemokine for NKT cells, and a series of elegant studies had already demonstrated that NKT cells accumulate in primary biliary cirrhosis (PBC)(46) and proven that such NKT cell accumulation drives local production of interferon (IFN)-γ, resulting in PBC-related bile duct injury.(47) The amount of Cxcl16 soluble protein was examined by ELISA in supernatants of freshly isolated primary cholangiocytes (Fig 4A–B), and in 603B cholangiocytes that were cultured alone or with MF-HSC in the transwell co-culture system (Fig 4C–D). Primary cholangiocytes from BDL rats released almost 16 times more Cxcl16 than cholangiocytes from sham controls (Fig. 4A), and co-cultured 603B cholangiocytes released about twice as much Cxcl16 protein as 603B mono-cultures (Fig. 4C). No Cxcl16 was detected in conditioned medium from mono-cultured MF-HSC (data not shown). Hence, this Cxcl16 was produced by the cholangiocytes in the co-culture. In both freshly isolated cholangiocytes and 603B cells, MF-HSC-derived Hh ligands were largely responsible for stimulating cholangiocyte production of Cxcl16 because Cxcl16 secretion was significantly inhibited by pre-treating MF-HSC conditioned medium with Hh-neutralizing antibody (but not control IgG) (Fig. 4B, D). Hh-neutralizing antibodies also blocked cholangiocyte mRNA expression of Adam10,(48, 49) an enzyme that is required to release membrane-associated Cxcl16 from cells that synthesize this chemokine (Fig. 4E).
Fig. 4. Hh-dependent paracrine signaling caused ductular cells to secrete the NKT chemokine Cxcl16 and chemoattracted NKT cells in vitro.
(A) Cxcl16 soluble protein analysis in primary cholangiocytes. Primary cholangiocytes were freshly isolated from sham or BDL rats. Supernatants were collected after 6 hours of incubation and analyzed for Cxcl16 by ELISA assay. (B) Effect of Hh ligand neutralization on Cxcl16 protein release by primary cholangiocytes. Freshly isolated cholangiocytes from normal rats were treated for 6 hours with either unconditioned medium (white bars) or 6 day MF-conditioned medium in presence of Hh ligand neutralizing antibody (5E1) (grey bars) or control IgG (black bars) (10μg/ml). Cxcl16 protein released into the supernatants was assessed by ELISA assay. (C) Cxcl16 soluble protein analysis in 603B cholangiocyte mono-/co-cultures. Conditioned medium was collected from 6 day mono- or co-cultures and Cxcl16 protein production was quantified by ELISA assay (D) Effect of Hh ligand neutralization on Cxcl16 protein release by 603B cholangiocytes. 6 day MF-conditioned medium was collected and added to mono-cultures of cholangiocytes in presence of Hh-neutralizing antibody (5E1) (grey bars) or control IgG (black bars) (10 μg/mL). 603B cells cultured with unconditioned medium (white bars) were used as controls. Supernatants were assessed by ELISA for Cxcl16 soluble protein levels, and cell pellets were analyzed by QRT-PCR for Adam10 gene expression. (E) (F) NKT cell migration assay. Cholangiocytes were cultured in absence/presence of MF-HSC. After 6 days, transwell filter inserts containing MF-HSC were removed. Cholangiocyte mono-/co-cultures were pre-treated for 1 hour with antibody neutralizing Cxcl16 or irrelevant IgG (5μg/mL). NKT cells were then added to the system using 5μm pore inserts, and their migration was monitored for 2 hours. Data are representative of 3 independent experiments and displayed as mean±SEM. (*P<0.05, ** P<0.005)
To examine the biological activity of cholangiocyte-derived Cxcl16, murine iNKT cells were then added to the upper well of transwell systems that contained cholangiocytes (that had either been grown for 6 days in mono-culture or co-culture with HSC-MF) in the bottom chamber. NKT cell migration was monitored for 2 hours in the absence or presence of anti-Cxcl16 antibody. Mono-cultured cholangiocytes evoked some NKT cell migration, but significantly more NKT cells migrated towards the co-cultured cholangiocytes. In both cases, anti-Cxcl16 blocked migration, proving that the NKT cells were chemoattracted by cholangiocyte-derived Cxcl16 (Fig. 4F). Together with the data displayed in Fig. 3, these results identify a Hh-dependent, paracrine mechanism by which MF-HSC stimulate cholangiocytes to synthesize and secrete Cxcl16, which then chemoattracts NKT cells to the Cxcl16-producing ductular cells.
Hh-associated induction of Cxcl16 production by ductular cells in PBC patients with NKT cell-mediated bile duct injury
PBC is characterized by chronic non-suppurative cholangitis that eventually destroys intralobular bile ducts, causing ductopenia and biliary-type fibrosis. It is not entirely clear why portal tracts accumulate iNKT cells in PBC patients and murine models of PBC, but it is known that the iNKT cells produce IFN-γ and contribute to bile duct injury because both IFN-γ and bile duct injury are prevented in PBC-prone mice that are genetically deficient in iNKT cells.(46, 47) Previously, we reported that Hh pathway activity is increased in the livers of PBC patients, resulting in induction of Hh-target genes in many of the ductular-type cells.(5, 8) Here we examined liver samples from 13 patients with PBC and 7 control healthy livers. QRT-PCR analysis showed that Gli2 mRNA level was virtually undetectable in control livers, while it was significantly induced in samples from PBC patients (P<0.05 PBC vs controls); Gli2 induction was also accompanied by a 70% down-regulation of the Hh pathway inhibitor Hhip (Hh interacting protein) in PBC samples (P<0.05, data not shown), confirming our previous report that the Hh pathway is activated in patients with PBC.(5, 8)
Cxcl16 is a Hh-regulated gene in cholangiocytes (Fig. 3). To clarify whether or not the reactive Cxcl16-producing cholangiocytes reside in the same CK-7(+) compartment that has been shown to be Hh-responsive,(5, 50) we performed hepatic double immunofluorescent staining to localize Cxcl16 expression in adults with PBC. Cxcl16 expression co-localized with that of CK-7, a marker of immature ductular cells (Fig. 4A–D). Hepatic expression of Cxcl16 mRNA and IFN-γ were also significantly greater in PBC patients than in controls without chronic liver disease (Fig. 4E–F). These findings complement and extend results obtained by studying Ptc+/− (Fig. 3B), strengthening support for the concept that activation of the Hh pathway during biliary injury induces immune responses, including recruitment of NKT cells, that amplify cholestatic liver damage.
DISCUSSION
The healthy liver is an immune organ, harboring large numbers of resident macrophages, dendritic cells, and various types of lymphocytes. During many types of chronic liver injury, populations of immune cells expand and some of these cells clearly contribute to liver damage by exerting direct cytotoxicity, generating reactive oxygen and/or reactive nitrogen species, and/or releasing hepatotoxic cytokines, such as IFN-γ. Several processes appear to be involved in expanding and activating immune cells in the liver, including presentation of foreign antigens (or altered self epitopes) by various types of resident liver cells, release of factors from dying liver cells, and hepatic induction of various chemokines and other factors that promote adhesion and viability of different types of immune cells. The present study identifies a unifying mechanism that may help to initiate and coordinate these diverse responses, namely injury-related activation of the Hedgehog pathway.
Two of the major cell types that are involved in adult liver repair, myofibroblastic stellate cell and ductular cells, produce and respond to Hh ligands.(5–8, 11, 50) Herein we demonstrated that Hh ligands dramatically up-regulate ductular cell expression of genes that promote antigen presentation and processing, inflammatory responses, and chemotaxis of neutrophils, monocytes/macrophages, B cells, T cells, NKT cells, and dendritic cells. A more in-depth evaluation of one of these Hh-regulated gene products, Cxcl16, provides evidence that these gene expression changes are likely to have functional relevance. Hh-dependent induction of Cxcl16 resulted in NKT cell chemotaxis towards cholangiocytes in vitro. Moreover, Hh-related induction of Cxcl16 was demonstrated in both bile duct ligated rats and humans with PBC, types of biliary injury in which NKT cells play a pivotal pathogenic role.
In both BDL mice(51) and humans with PBC,(46) bile duct destruction involves NKT cell-mediated increases in IFN-γ because inhibiting IFN-γ production is protective. Both BDL and PBC promote biliary fibrosis and may ultimately result in biliary-type cirrhosis.(2) The mechanisms that couple chronic biliary injury to fibrosis are not fully understood, however. Indeed, IFN-γ (the putative mediator of cholangiocyte death) has significant anti-fibrotic actions. Hence, other factors must be involved.
Several lines of evidence suggest that the Hh pathway modulates the sequelae of cholangiocyte death. Hh ligands promote the expansion of both liver myofibroblastic cells and progenitor cell populations.(6, 7, 10, 11, 52) The former occurs, at least in part, via Hh-mediated induction of epithelial-to-mesenchymal transition (EMT) in ductular-type progenitor cells.(5) Hence, sustained Hh pathway activation, as occurs during chronic biliary injury, diverts progenitors away from bile duct cell replacement and promotes their differentiation into myofibroblastic cells. Myofibroblastic liver cells produce Hh ligands (7, 11) and the latter help to maintain their myofibroblastic phenotype by up-regulating Snail and inducing mesenchymal gene expression, while repressing expression of bone morphogenic protein (BMP-7), E-cadherin, and other factors that support epithelial differentiation (Choi SS, unpublished data). Therefore, eventual ductopenia and bilary-type fibrosis are the predicted outcomes of persistent Hh pathway activation during conditions that cause repeated death of mature biliary epithelial cells. Other Hh-regulated factors may fuel this process. For example, Hh-mediated induction of β2-microglubulin might amplify cholangiocyte presentation of altered self-antigens, while increased expression of Hh-regulated T and B cell chemokines may recruit cytotoxic lymphocytes into the liver and/or stimulate local production of antibodies that trigger further bile duct injury. Similarly, Hh-related increases in Ccl2/MCP1 might enhance hepatic recruitment of bone marrow-derived fibrocytes, and myofibroblast trans-differentiation of portal fibroblasts,(53) worsening liver fibrosis.
Although the current study focused on Hh signaling during chronic cholestatic liver damage, Hh pathway activation has been demonstrated in other types of adult liver disease, including nonalcoholic and alcoholic fatty liver diseases,(52) cholangiocarcinoma,(54) and hepatocellular carcinoma.(10, 55) Hepatic accumulation of inflammatory cells, myofibroblasts, liver progenitors, and fibrosis may also occur in each of these conditions. The results of the present study provide a compelling rationale for investigating the causes and consequences of Hh pathway activation in these other disorders. Such work may identify novel biomarkers and therapeutic targets that could improve the outcomes of an array of chronic diseases for which, at present, there are few effective treatments.
Fig. 5. Cxcl16 localizes in Hh-responsive immature epithelial cells in PBC.
(A–D) Double immunofluorescent staining. Cxcl16 (A) and CK-7 (B) co-localized (C–D) in representative sections from PBC liver. Normal liver co-staining failed to demonstrate CK-7/Cxcl16 double positive cells (C, NL insert). In all merged images, blue DAPI-staining demonstrates cell nuclei. (A–C) Original magnification ×40. (D) Magnified section of the indicated area in panel C. (E–F) QRT-PCR Analysis of whole liver tissue from13 patients with PBC and 7 control healthy livers (NL). (E) Cxcl16; (F) IFNγ. Data are expressed as as mean±SEM (*P<0.05 vs NL).
Acknowledgments
The authors thank W. C. Stone for his administrative support and are grateful to J. Venter, R. Mancinelli and M. Marzioni for their outstanding technical support and advice, respectively. The authors thank Y. Ueno (Tohoku University, Sendai, Japan) and G. Gores (Mayo Clinic, Rochester, MN) for the gift of the murine cholangiocyte cell line 603B, N. LaRusso (Mayo Clinic, Rochester, MN) for providing the normal rat cholangiocyte line (NRC), M. Rojkind for sharing the myofibroblast cell line MF-HSC-8B and A. Bendelac (University of Chicago, Chicago, IL) for the gift of the murine invariant NKT hybridoma cell line. The 5E1 antibody developed by Thomas M. Jessel was obtained from the Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA 52242, USA
Financial Support
This work was supported in part by funding from the NIH grant RO1-DK-077794 to Dr. Anna Mae Diehl, and the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott & White, the VA Research Scholar Award, a VA Merit Award to Dr. G. Alpini.
List of Abbreviations
- Hh
Hedgehog
- MF-HSC
Myofibroblastic Hepatic Stellate Cell
- Cxcl16
chemokine (C-X-C) motif ligand 16
- NKT
Natural Killer T
- IFNγ
Interferon γ
- PBC
Primary Biliary Cirrhosis
- CK-7
Cytokeratin-7
- Ptc
Patched
- WT
Wild type
- BDL
Bile Duct Ligation
- γ GT
γ glutamil transpeptidase, DAPI, 4′,6-diamidino-2-phenylindole
- Ccl2/MCP-1
chemokine (C-C) motif ligand 2/monocyte chemotactic protein-1
- Ccl5
chemokine (C-C) motif ligand 5
- Ccl20/MIP3α chemokine (C-C) motif ligand 20/macrophage inflammatory protein-3α
Cxcl1, chemokine (C-X-C) motif ligand 1
- Cxcl2
chemokine (C-X-C) motif ligand 2
- Cxcl5
chemokine (C-X-C) motif ligand 5
- Cxcl10
chemokine (C-X-C) motif ligand 10
- Cxcl11
chemokine (C-X-C) motif ligand 11
- BMP-7
bone morphogenic protein-7
Contributor Information
Alessia Omenetti, Email: alessia.omenetti@duke.edu.
Wing-Kin Syn, Email: wing-kin.syn@duke.edu.
Youngmi Jung, Email: youngmi.jung@duke.edu.
Heather Francis, Email: hfrancis@tamu.edu.
Alessandro Porrello, Email: porre001@duke.edu.
Rafal P. Witek, Email: rafalp.witek@duke.edu.
Steve S. Choi, Email: steve.choi@duke.edu.
Liu Yang, Email: yang.liu@mayo.edu.
Marlyn Mayo, Email: Marlyn.Mayo@UTSouthwestern.edu.
M. Eric Gershwin, Email: megershwin@ucdavis.edu.
Gianfranco Alpini, Email: galpini@tamu.edu.
Anna Mae Diehl, Email: annamae.diehl@duke.edu.
References
- 1.Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007;117:539–548. doi: 10.1172/JCI30542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology. 2004;127:1565–1577. doi: 10.1053/j.gastro.2004.08.006. [DOI] [PubMed] [Google Scholar]
- 3.Marra F. Chemokines in liver inflammation and fibrosis. Front Biosci. 2002;7:d1899–1914. doi: 10.2741/A887. [DOI] [PubMed] [Google Scholar]
- 4.Henderson NC, Iredale JP. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond) 2007;112:265–280. doi: 10.1042/CS20060242. [DOI] [PubMed] [Google Scholar]
- 5.Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS, Witek RP, Alpini G, Ventr J, Vandongen HM, Syn W, Svegliati Baroni G, Benedetti A, Schuppan D, Diehl AM. Hedgehog signaling regulates epithelial-mesenchimal transition during biliary fibrosis in rodents and humans. JCI. 2008 doi: 10.1172/JCI35875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Omenetti A, Popov Y, Jung Y, Choi SS, Witek RP, Yang L, Brown KD, et al. The Hedgehog Pathway Regulates Remodeling Responses to Biliary Obstruction in Rats. Gut. 2008 doi: 10.1136/gut.2008.148619. [DOI] [PubMed] [Google Scholar]
- 7.Omenetti A, Yang L, Li YX, McCall SJ, Jung Y, Sicklick JK, Huang J, et al. Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest. 2007;87:499–514. doi: 10.1038/labinvest.3700537. [DOI] [PubMed] [Google Scholar]
- 8.Jung Y, McCall SJ, Li YX, Diehl AM. Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. Hepatology. 2007;45:1091–1096. doi: 10.1002/hep.21660. [DOI] [PubMed] [Google Scholar]
- 9.Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol. 2005;6:306–317. doi: 10.1038/nrm1622. [DOI] [PubMed] [Google Scholar]
- 10.Omenetti A, Diehl AM. The Adventures of Sonic Hedgehog in Development and Repair. II. Sonic hedgehog and liver development, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol. 2008;294:G595–598. doi: 10.1152/ajpgi.00543.2007. [DOI] [PubMed] [Google Scholar]
- 11.Yang L, Wang Y, Mao H, Fleig S, Omenetti A, Brown KD, Sicklick JK, et al. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol. 2008;48:98–106. doi: 10.1016/j.jhep.2007.07.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lowrey JA, Stewart GA, Lindey S, Hoyne GF, Dallman MJ, Howie SE, Lamb JR. Sonic hedgehog promotes cell cycle progression in activated peripheral CD4(+) T lymphocytes. J Immunol. 2002;169:1869–1875. doi: 10.4049/jimmunol.169.4.1869. [DOI] [PubMed] [Google Scholar]
- 13.Stewart GA, Lowrey JA, Wakelin SJ, Fitch PM, Lindey S, Dallman MJ, Lamb JR, et al. Sonic hedgehog signaling modulates activation of and cytokine production by human peripheral CD4+ T cells. J Immunol. 2002;169:5451–5457. doi: 10.4049/jimmunol.169.10.5451. [DOI] [PubMed] [Google Scholar]
- 14.Heydtmann M, Lalor PF, Eksteen JA, Hubscher SG, Briskin M, Adams DH. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol. 2005;174:1055–1062. doi: 10.4049/jimmunol.174.2.1055. [DOI] [PubMed] [Google Scholar]
- 15.Reynoso-Paz S, Coppel RL, Mackay IR, Bass NM, Ansari AA, Gershwin ME. The immunobiology of bile and biliary epithelium. Hepatology. 1999;30:351–357. doi: 10.1002/hep.510300218. [DOI] [PubMed] [Google Scholar]
- 16.Fava G, Glaser S, Francis H, Alpini G. The immunophysiology of biliary epithelium. Semin Liver Dis. 2005;25:251–264. doi: 10.1055/s-2005-916318. [DOI] [PubMed] [Google Scholar]
- 17.Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science. 1997;277:1109–1113. doi: 10.1126/science.277.5329.1109. [DOI] [PubMed] [Google Scholar]
- 18.Yahagi K, Ishii M, Kobayashi K, Ueno Y, Mano Y, Niitsuma H, Igarashi T, et al. Primary culture of cholangiocytes from normal mouse liver. In Vitro Cell Dev Biol Anim. 1998;34:512–514. doi: 10.1007/s11626-998-0106-x. [DOI] [PubMed] [Google Scholar]
- 19.Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. Gastroenterology. 2005;128:1354–1368. doi: 10.1053/j.gastro.2005.01.055. [DOI] [PubMed] [Google Scholar]
- 20.Greenwel P, Schwartz M, Rosas M, Peyrol S, Grimaud JA, Rojkind M. Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest. 1991;65:644–653. [PubMed] [Google Scholar]
- 21.Vroman B, LaRusso NF. Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells. Lab Invest. 1996;74:303–313. [PubMed] [Google Scholar]
- 22.Lantz O, Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4–8- T cells in mice and humans. J Exp Med. 1994;180:1097–1106. doi: 10.1084/jem.180.3.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, Fava G, et al. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. Gastroenterology. 2007;133:244–255. doi: 10.1053/j.gastro.2007.04.007. [DOI] [PubMed] [Google Scholar]
- 24.Hara T, Katakai T, Lee JH, Nambu Y, Nakajima-Nagata N, Gonda H, Sugai M, et al. A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesion. Int Immunol. 2006;18:301–311. doi: 10.1093/intimm/dxh369. [DOI] [PubMed] [Google Scholar]
- 25.Shimizu Y, Murata H, Kashii Y, Hirano K, Kunitani H, Higuchi K, Watanabe A. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver. Hepatology. 2001;34:311–319. doi: 10.1053/jhep.2001.26631. [DOI] [PubMed] [Google Scholar]
- 26.Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185–193. doi: 10.1093/bioinformatics/19.2.185. [DOI] [PubMed] [Google Scholar]
- 27.Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15. doi: 10.1093/nar/gng015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–264. doi: 10.1093/biostatistics/4.2.249. [DOI] [PubMed] [Google Scholar]
- 29.Shackel NA, Gorrell MD, McCaughan GW. Gene array analysis and the liver. Hepatology. 2002;36:1313–1325. doi: 10.1053/jhep.2002.36950. [DOI] [PubMed] [Google Scholar]
- 30.Pavlidis P, Li Q, Noble WS. The effect of replication on gene expression microarray experiments. Bioinformatics. 2003;19:1620–1627. doi: 10.1093/bioinformatics/btg227. [DOI] [PubMed] [Google Scholar]
- 31.Creating the gene ontology resource: design and implementation. Genome Res. 2001;11:1425–1433. doi: 10.1101/gr.180801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hosack DA, Dennis G, Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:R70. doi: 10.1186/gb-2003-4-10-r70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Luster AD. Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436–445. doi: 10.1056/NEJM199802123380706. [DOI] [PubMed] [Google Scholar]
- 34.Marra F, DeFranco R, Grappone C, Parola M, Milani S, Leonarduzzi G, Pastacaldi S, et al. Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J Investig Med. 1999;47:66–75. [PubMed] [Google Scholar]
- 35.Krzysiek R, Lefevre EA, Bernard J, Foussat A, Galanaud P, Louache F, Richard Y. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells. Blood. 2000;96:2338–2345. [PubMed] [Google Scholar]
- 36.Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol. 1999;162:186– 194. [PubMed] [Google Scholar]
- 37.Liao F, Shirakawa AK, Foley JF, Rabin RL, Farber JM. Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol. 2002;168:4871–4880. doi: 10.4049/jimmunol.168.10.4871. [DOI] [PubMed] [Google Scholar]
- 38.Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003;14:409–426. doi: 10.1016/s1359-6101(03)00049-2. [DOI] [PubMed] [Google Scholar]
- 39.Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998;187:2009–2021. doi: 10.1084/jem.187.12.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610–621. doi: 10.1056/NEJMra052723. [DOI] [PubMed] [Google Scholar]
- 41.Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, Greenberg HB, et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest. 2001;107:595–601. doi: 10.1172/JCI11902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol. 2000;1:298–304. doi: 10.1038/79738. [DOI] [PubMed] [Google Scholar]
- 43.Kalderon D. Transducing the hedgehog signal. Cell. 2000;103:371–374. doi: 10.1016/s0092-8674(00)00129-x. [DOI] [PubMed] [Google Scholar]
- 44.Lee Y, Miller HL, Russell HR, Boyd K, Curran T, McKinnon PJ. Patched2 modulates tumorigenesis in patched1 heterozygous mice. Cancer Res. 2006;66:6964–6971. doi: 10.1158/0008-5472.CAN-06-0505. [DOI] [PubMed] [Google Scholar]
- 45.Uhmann A, Ferch U, Bauer R, Tauber S, Arziman Z, Chen C, Hemmerlein B, et al. A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing. Int J Oncol. 2005;27:1567–1575. [PubMed] [Google Scholar]
- 46.Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS, Koning F, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology. 2002;123:1031–1043. doi: 10.1053/gast.2002.36020. [DOI] [PubMed] [Google Scholar]
- 47.Chuang YH, Lian ZX, Yang GX, Shu SA, Moritoki Y, Ridgway WM, Ansari AA, et al. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology. 2008;47:571–580. doi: 10.1002/hep.22052. [DOI] [PubMed] [Google Scholar]
- 48.Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol. 2004;172:6362–6372. doi: 10.4049/jimmunol.172.10.6362. [DOI] [PubMed] [Google Scholar]
- 49.Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol. 2004;172:3678–3685. doi: 10.4049/jimmunol.172.6.3678. [DOI] [PubMed] [Google Scholar]
- 50.Jung Y, Brown KD, Witek RP, Omenetti A, Yang L, Vandongen M, Milton RJ, et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology. 2008;134:1532–1543. doi: 10.1053/j.gastro.2008.02.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kahraman A, Barreyro FJ, Bronk SF, Werneburg NW, Mott JL, Akazawa Y, Masuoka HC, et al. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology. 2008;47:1317–1330. doi: 10.1002/hep.22136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Fleig SV, Choi SS, Yang L, Jung Y, Omenetti A, VanDongen HM, Huang J, et al. Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice. Lab Invest. 2007;87:1227–1239. doi: 10.1038/labinvest.3700689. [DOI] [PubMed] [Google Scholar]
- 53.Kruglov EA, Nathanson RA, Nguyen T, Dranoff JA. Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2006;290:G765–771. doi: 10.1152/ajpgi.00308.2005. [DOI] [PubMed] [Google Scholar]
- 54.Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432:324–331. doi: 10.1038/nature03100. [DOI] [PubMed] [Google Scholar]
- 55.Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P, Ludlow JW, et al. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis. 2006;27:748–757. doi: 10.1093/carcin/bgi292. [DOI] [PubMed] [Google Scholar]





